S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought

Cannabis Stocks List

Compare cannabis stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Learn more about trading Cannabis/Marijuana stocks.

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aphria Inc. stock logo
APHA
Aphria
$15.38
$15.48
$2.78
$32.29
$4.87 B2.6721.83 million shsN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
$0.40
-6.5%
$0.52
$0.35
$4.77
$252.38 M1.9415.01 million shs21.17 million shs
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
$218.96
$218.59
$87.07
$219.57
$6.86 B2.15899,771 shsN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$139.35
+3.1%
$128.06
$120.64
$163.31
$8.80 B0.73525,914 shs903,300 shs
Tilray Inc stock logo
TLRY
Tilray
$2.62
$1.86
$1.50
$5.12
$1.84 B2.6617.27 million shs21.92 million shs
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.53
+0.4%
$0.54
$0.48
$1.94
$200.51 M2.64.71 million shs3.41 million shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24 M1.35880,508 shs305,500 shs
Altria Group, Inc. stock logo
MO
Altria Group
$43.73
-0.4%
$44.93
$40.35
$51.57
$77.60 B0.597.75 million shs7.16 million shs
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$51.91
-1.6%
$63.22
$39.06
$88.61
$2.92 B1.62777,718 shs707,800 shs
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$2.98
-3.9%
$3.29
$2.19
$7.90
$1.86 BN/A517,607 shs680,100 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.00%-9.97%+4.84%-62.01%-87.80%
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
0.00%+7.08%+9.99%+3.47%-11.29%
Tilray Inc stock logo
TLRY
Tilray
0.00%+13.91%+57.83%+7.82%-34.99%
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%-2.74%-0.36%-9.04%-69.59%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%-49.65%-77.74%
Altria Group, Inc. stock logo
MO
Altria Group
0.00%-0.61%-3.87%-4.02%-3.15%
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
0.00%-6.64%-22.78%-23.65%-36.38%
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.00%-14.37%-19.89%+16.40%-50.78%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/AN/AN/AN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
1.9659 of 5 stars
3.04.00.00.03.30.81.3
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
2.9537 of 5 stars
4.54.00.04.03.12.51.3
Tilray Inc stock logo
TLRY
Tilray
1.4952 of 5 stars
2.02.00.00.03.00.01.3
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1.77 of 5 stars
3.00.00.00.02.70.01.3
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
Altria Group, Inc. stock logo
MO
Altria Group
1.9358 of 5 stars
1.05.04.20.02.60.81.9
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
2.5419 of 5 stars
3.42.01.71.52.34.21.9
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
2.2181 of 5 stars
4.44.00.00.01.60.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
2.00
Hold$2.56536.77% Upside
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
N/AN/AN/AN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
3.00
Buy$212.0052.13% Upside
Tilray Inc stock logo
TLRY
Tilray
2.00
Hold$3.1319.38% Upside
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
2.00
Hold$1.40163.11% Upside
HEXO Corp. stock logo
HEXO
HEXO
2.00
HoldN/AN/A
Altria Group, Inc. stock logo
MO
Altria Group
2.00
Hold$46.005.19% Upside
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
2.71
Moderate Buy$69.2933.47% Upside
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
2.73
Moderate Buy$7.15139.93% Upside

Current Analyst Ratings

Latest Cannabis Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2023
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$204.00
8/11/2023
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$3.50 ➝ C$3.00
8/10/2023
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$204.00 ➝ $217.00
8/10/2023
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$203.00 ➝ $201.00
8/10/2023
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.25
8/7/2023
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$226.00
8/7/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$68.00 ➝ $55.00
8/4/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$75.00 ➝ $65.00
8/3/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$80.00 ➝ $75.00
8/3/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetStrong-Buy ➝ Strong-Buy$86.00 ➝ $70.00
8/1/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$72.00 ➝ $68.00
(Data available from 8/14/2020 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aphria Inc. stock logo
APHA
Aphria
$405.96M12.00$0.09 per share166.43$4.80 per share3.20
Canopy Growth Co. stock logo
CGC
Canopy Growth
$304.79M0.83N/AN/A$1.01 per share0.40
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
$311.33M22.05$0.01 per share18,588.22$23.48 per share9.33
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$3.66B2.40$22.08 per share6.31$55.84 per share2.50
Tilray Inc stock logo
TLRY
Tilray
$210.48M8.75$0.00 per share2,886.61$5.07 per share0.52
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$211.59M0.95N/AN/A$2.31 per share0.23
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
Altria Group, Inc. stock logo
MO
Altria Group
$25.10B3.09$5.00 per share8.74($2.13) per share-20.53
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$3.92B0.74$6.05 per share8.58$2.40 per share21.63
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$1.34B1.39N/AN/A$2.07 per share1.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aphria Inc. stock logo
APHA
Aphria
-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
-$2.48B-$1.76N/AN/AN/A-278.33%-49.88%-21.05%11/8/2023 (Estimated)
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
-$9.02M-$0.24N/A608.22N/A-11.05%-7.46%-6.13%N/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
-$224.06M-$1.57N/A8.311.09-2.30%24.47%7.13%11/8/2023 (Estimated)
Tilray Inc stock logo
TLRY
Tilray
-$1.45B-$2.29N/AN/AN/A-226.15%-3.45%-2.76%10/6/2023 (Estimated)
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$1.36B-$0.52N/AN/AN/A-88.27%-30.47%-16.50%11/9/2023 (Estimated)
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%10/30/2023 (Estimated)
Altria Group, Inc. stock logo
MO
Altria Group
$5.76B$3.8111.488.462.3427.40%-225.61%24.54%10/26/2023 (Estimated)
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
-$437.50M-$2.43N/A16.32N/A-3.59%91.85%2.41%11/1/2023 (Estimated)
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$370.10M-$0.60N/AN/AN/A-31.99%-22.78%-8.83%N/A

Latest Cannabis Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/2/2023Q3 2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$1.41$1.17-$0.24$1.57$1.15 billion$1.12 billion    
8/1/2023Q2 23
Altria Group, Inc. stock logo
MO
Altria Group
$1.31$1.31N/A$1.43$5.43 billion$5.44 billion      
6/22/2023Q4 2023
Canopy Growth Co. stock logo
CGC
Canopy Growth
-$0.12-$0.23-$0.11$0.49$72.53 million$64.74 million
6/14/2023Q3 2023
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$0.04-$0.15-$0.11-$0.12$47.89 million$47.35 million
6/14/2023Q3 2023
HEXO Corp. stock logo
HEXO
HEXO
-$0.07-$0.70-$0.63$0.54$18.50 million$15.63 million
5/17/2023Q1 2023
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$0.05-$0.05N/A-$0.03$332.21 million$336.50 million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
N/AN/AN/AN/AN/A
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
N/AN/AN/AN/AN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
N/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
N/AN/AN/AN/AN/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
Altria Group, Inc. stock logo
MO
Altria Group
$3.768.60%+3.91%98.69%13 Years
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$2.645.09%+5.32%N/A N/A
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
N/AN/AN/AN/AN/A

Latest Cannabis Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/1/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Quarterly$0.664.56%8/24/20238/25/20239/8/2023
5/18/2023
Altria Group, Inc. stock logo
MO
Altria Group
Quarterly$0.948.3%6/14/20236/15/20237/10/2023
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aphria Inc. stock logo
APHA
Aphria
0.25
2.36
1.17
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.93
1.96
1.15
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
0.01
5.13
4.31
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
1.61
3.18
2.32
Tilray Inc stock logo
TLRY
Tilray
0.11
1.79
1.32
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.33
4.08
3.16
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
Altria Group, Inc. stock logo
MO
Altria Group
N/A
0.37
0.27
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
19.50
1.69
1.03
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.73
1.10
0.62

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aphria Inc. stock logo
APHA
Aphria
1,200316.80 millionN/AOptionable
Canopy Growth Co. stock logo
CGC
Canopy Growth
1,621626.73 million625.48 millionOptionable
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
1,16131.35 millionN/AOptionable
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
2,80063.13 million60.36 millionOptionable
Tilray Inc stock logo
TLRY
Tilray
1,600703.26 million685.39 millionOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,338376.84 million376.80 millionOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
Altria Group, Inc. stock logo
MO
Altria Group
6,3001.77 billion1.77 billionOptionable
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
6,10056.16 million40.84 millionOptionable
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
5,931624.28 millionN/ANot Optionable

Cannabis Stocks Headlines

SourceHeadline
Curaleaf (OTCMKTS:CURLF) Rating Reiterated by Needham & Company LLCCuraleaf (OTCMKTS:CURLF) Rating Reiterated by Needham & Company LLC
americanbankingnews.com - August 12 at 6:42 AM
Curaleafs Boris Jordan: No Capital Raises Planned, Company Has $50M In Revolving CreditCuraleaf's Boris Jordan: No Capital Raises Planned, Company Has $50M In Revolving Credit
benzinga.com - August 11 at 6:56 PM
Curaleaf (OTCMKTS:CURLF) PT Lowered to C$3.00 at Stifel NicolausCuraleaf (OTCMKTS:CURLF) PT Lowered to C$3.00 at Stifel Nicolaus
marketbeat.com - August 11 at 5:49 PM
Analysts Offer Predictions for Curaleaf Holdings, Inc.s Q1 2024 Earnings (OTCMKTS:CURLF)Analysts Offer Predictions for Curaleaf Holdings, Inc.'s Q1 2024 Earnings (OTCMKTS:CURLF)
americanbankingnews.com - August 11 at 3:30 AM
Curaleaf Sees Losses Climb In Q2Curaleaf Sees Losses Climb In Q2
thedeepdive.ca - August 10 at 10:01 AM
Curaleaf Holdings, Inc. to Post FY2023 Earnings of ($0.22) Per Share, Seaport Res Ptn Forecasts (OTCMKTS:CURLF)Curaleaf Holdings, Inc. to Post FY2023 Earnings of ($0.22) Per Share, Seaport Res Ptn Forecasts (OTCMKTS:CURLF)
americanbankingnews.com - August 10 at 8:36 AM
Curaleaf Holdings, Inc.: Curaleaf Reports Second Quarter 2023 ResultsCuraleaf Holdings, Inc.: Curaleaf Reports Second Quarter 2023 Results
finanznachrichten.de - August 10 at 8:25 AM
Curaleafs Select™ Brand Expands Product Offerings With Launch of Select Liquid DiamondsCuraleaf's Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds
finance.yahoo.com - August 10 at 8:25 AM
Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue EstimatesCuraleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 9 at 8:07 PM
Curaleaf Q2 Revenue Lifts 1% SequentiallyCuraleaf Q2 Revenue Lifts 1% Sequentially
newcannabisventures.com - August 9 at 6:51 PM
Curaleaf Reports Second Quarter 2023 ResultsCuraleaf Reports Second Quarter 2023 Results
finance.yahoo.com - August 9 at 6:51 PM
Earnings Outlook For Curaleaf HoldingsEarnings Outlook For Curaleaf Holdings
benzinga.com - August 8 at 2:04 PM
Curaleaf (OTCMKTS:CURLF) Rating Lowered to Sell at Stifel NicolausCuraleaf (OTCMKTS:CURLF) Rating Lowered to Sell at Stifel Nicolaus
americanbankingnews.com - August 4 at 6:02 AM
Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Given Average Recommendation of "Moderate Buy" by BrokeragesCuraleaf Holdings, Inc. (OTCMKTS:CURLF) Given Average Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - July 27 at 1:31 AM
We Financial Senior Account Manager Steve Rivera Comments on Curaleaf’s Plans To List on TSXWe Financial Senior Account Manager Steve Rivera Comments on Curaleaf’s Plans To List on TSX
techbullion.com - July 26 at 5:07 PM
New Jersey marijuana advocates question Curaleaf layoffsNew Jersey marijuana advocates question Curaleaf layoffs
mjbizdaily.com - July 25 at 7:49 PM
New Jersey Marijuana Supply Levels Remain In Question As Curaleaf Moves To Shutter Cultivation FacilityNew Jersey Marijuana Supply Levels Remain In Question As Curaleaf Moves To Shutter Cultivation Facility
marijuanamoment.net - July 24 at 7:21 PM
Cannabis Giant Curaleaf Trims Workforce in New Jersey Amid Market GlutCannabis Giant Curaleaf Trims Workforce in New Jersey Amid Market Glut
benzinga.com - July 20 at 3:25 PM
Marijuana MSO Curaleaf lays off 49 employees in New JerseyMarijuana MSO Curaleaf lays off 49 employees in New Jersey
mjbizdaily.com - July 19 at 6:57 PM
Curaleaf plans more South Jersey layoffsCuraleaf plans more South Jersey layoffs
njbiz.com - July 18 at 2:48 PM
Curaleaf Seeks Reorganization Of US Assets To List On TSXCuraleaf Seeks Reorganization Of US Assets To List On TSX
thedeepdive.ca - July 17 at 7:48 PM
New Mobile App For Cannabis Users To Order Favorite Products, Read About Discounts And MoreNew Mobile App For Cannabis Users To Order Favorite Products, Read About Discounts And More
benzinga.com - July 12 at 9:09 AM
Curaleaf to Report Second Quarter 2023 Financial and Operational ResultsCuraleaf to Report Second Quarter 2023 Financial and Operational Results
finance.yahoo.com - July 12 at 9:09 AM
Groton Curaleaf adds recreational cannabis sale to dispensaryGroton Curaleaf adds recreational cannabis sale to dispensary
stamfordadvocate.com - July 10 at 12:57 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Aphria logo

Aphria

NASDAQ:APHA
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Canopy Growth logo

Canopy Growth

NASDAQ:CGC
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
GW Pharmaceuticals logo

GW Pharmaceuticals

NASDAQ:GWPH
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

NASDAQ:JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, such as hematologic and solid tumors. Its lead marketed products in neuroscience include Xywav, an oral solution for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy and idiopathic hypersomnia (IH); Xyrem, a sodium oxybate oral solution for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older; and Epidiolex, a cannabidiol oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex in patients one year of age or older. The company's lead marketed products in oncology comprise Zepzelca for the treatment of adult patients with metastatic small cell lung cancer; Rylaze, a product for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adults and pediatric patients aged one month or older who has developed hypersensitivity to E. coli-derived asparaginase; Vyxeos, a liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation. It has licensing and collaboration agreements with Zymeworks Inc.; Sumitomo Pharma Co., Ltd; Werewolf Therapeutics, Inc.; Codiak BioSciences, Inc.; Ligand Pharmaceuticals Incorporated; XL-protein GmbH; and Redx Pharma plc. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.
Tilray logo

Tilray

NASDAQ:TLRY
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Aurora Cannabis logo

Aurora Cannabis

NYSE:ACB
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.
HEXO logo

HEXO

NYSE:HEXO
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.
Altria Group logo

Altria Group

NYSE:MO
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; moist smokeless tobacco products and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; and on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.
Scotts Miracle-Gro logo

Scotts Miracle-Gro

NYSE:SMG
The Scotts Miracle-Gro Company is involved in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. It operates through three segments: U.S. Consumer, Hawthorne, and Other. The company provides lawn care products comprising lawn fertilizers, grass seed products, spreaders, other durable products, and outdoor cleaners, as well as lawn-related weed, pest, and disease control products; gardening and landscape products comprising water-soluble and continuous-release plant foods, potting mixes and garden soils, mulch and decorative groundcover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions. It also offers hydroponic products that help users to grow plants, flowers, and vegetables using little or no soil; lighting systems and components for use in hydroponic and indoor gardening applications; insect, rodent, and weed control products for home areas; and non-selective weed killer products. The company sells its products under the Scotts, Turf Builder, EZ Seed, PatchMaster, Thick'R Lawn, GrubEx, EdgeGuard, Handy Green II, Miracle-Gro, LiquaFeed, Shake N Feed, Hyponex, Earthgro, Nature Scapes, Ortho, Miracle-Gro Performance Organics, Miracle-Gro Organic Choice, Whitney Farms, EcoScraps, Mother Earth, Botanicare, General Hydroponics, Vermicrop, Cyco, Gavita, Agrolux, HydroLogic, Can-Filters, Gro Pro, Hurricane, AeroGarden, Titan, Tomcat, Ortho Weed B Gon, Roundup, Groundclear, and Alchemist brands. It serves home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, and food and drug stores, as well as indoor gardening and hydroponic distributors, retailers, and growers. The company was founded in 1868 and is headquartered in Marysville, Ohio.
Curaleaf logo

Curaleaf

OTCMKTS:CURLF
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

Key Points

  • The size and scope of the cannabis industry can take your breath away — it's not just about farmers growing marijuana plants or your local dispensary. 
  • Growers, dispensaries and pharmaceutical companies provide the infrastructure for the industry. 
  • Learn the steps ensure you understand the opportunities in cannabis investment. 

Learning how to invest in cannabis is not for risk-averse investors. If you were investing in cannabis in 2017 and 2018, you know how far and how fast these stocks can rise and fall. 

Still, the potential for this industry remains tantalizing. Before you invest your hard-earned capital in this sector, you need to understand the different types of cannabis investments, the risks of investing in cannabis and the eight steps you can take to invest in cannabis. 

Basics of the Cannabis Industry

The size and scope of the cannabis industry can take your breath away — it's not just about farmers growing marijuana plants or your local dispensary. 

The cannabis industry ties in growers, dispensaries, pharmaceutical companies and companies that help provide the infrastructure. It's a complex industry of intertwined interests and made even more complicated because cannabis remains a banned substance by the federal government. 

That hasn't stopped individual states from taking up the question of cannabis regulation, but that creates another obstacle. There is no uniform status regarding the legal status of cannabis. 

The good news if you're interested in cannabis investing is that as of January 2023, only six states (North Carolina, South Carolina, Nebraska, Kansas, Idaho and Wyoming) have not legalized cannabis at any level. You may be equally surprised to find that 22 states have made cannabis fully legal, meaning you can use it for recreational and medicinal purposes. 

Now, the bad news. Investors looking to invest in weed face an uphill climb. Even in states where cannabis is no longer decriminalized, some restrictions are tied to how much individuals can possess and grow. The remaining 23 states have varying legal standards that make cannabis regulation a crazy quilt for cannabis companies to navigate, as the chart below shows. 

how to invest in cannabis

Status of Cannabis Legalization by State

This chart provides a broad overview of the status of cannabis legalization in the United States. There are nuances in many states that you can research by state

Fully Legal (Recreational and Medical Use

Legal for Medical Use Only

Legal for CBD Oil Only 

Not Legal

Alaska

Arkansas

Alabama (non-psychoactive)

Idaho

Arizona

Delaware

Georgia

Kansas

California

Florida

Indiana

Nebraska**

Colorado

Oklahoma

Iowa

North Carolina***

Connecticut

Pennsylvania

Kentucky

South Carolina

District of Columbia

South Dakota

Tennessee

Wyoming

Hawaii*

Utah

Texas

 

Illinois

West Virginia

Wisconsin

 

Louisiana*

     

Maine

     

Maryland

     

Massachusetts

     

Michigan

     

Minnesota*

     

Mississippi*

     

Missouri

     

Montana

     

New Hampshire*

     

New Mexico

     

New Jersey

     

New York

     

Nevada

     

North Dakota*

     

Ohio*

     

Oregon

     

Rhode Island

     

Vermont

     

Virginia

     

Washington

     

*Although technically considered not fully legal, these states have passed laws that allow for the use of cannabis for medical and recreational purposes with heavy restrictions.

**Although officially illegal, Nebraska has passed laws decriminalizing small amounts of marijuana.

***North Carolina allows CBD oil for patients with treatment-resistant epilepsy.

Overview of Cannabis Stocks

If you're considering investing in cannabis stocks, the chart above shows both the short-term risk and the long-term opportunity. Taking advantage of this opportunity starts by considering what kind of cannabis stocks you want to buy. 

But first, a word of caution. Cannabis investments are inherently risky. Many of these companies are small-cap companies (meaning they have a market cap of less than $2 billion). 

The risk is that small-cap stocks frequently have less liquidity than their large-cap counterparts. That means sending the prices moving in either direction doesn't take much. And when the stock price makes a sharp move, you can lose a lot of money if you're on the wrong side of the trade. 

The other risk comes from the financial situation of many cannabis companies. Even when the cannabis bubble blew up in 2018 and early 2019, many companies were not profitable. Many of these stocks are trading as penny stocks, meaning they trade for $5 or less. Be sure to learn about penny stocks before investing.

The takeaway is that investing in cannabis in 2023 is not like choosing from a list of FAANG stocks. And it's nothing like blue-chip investing. This sector is only for risk-tolerant investors. With that in mind, let's look at the type of cannabis investments.

Types of Cannabis Investments

As mentioned earlier, several types of companies make up the cannabis industry. This list includes growers, retailers (dispensaries), pharmaceutical companies and companies that help provide the infrastructure for the cannabis industry. Here's a brief overview of each type of cannabis investment.

Growers

Also known as cultivation, this is the sector where companies breed and produce a variety of cannabis strains. These companies employ individuals who have extensively worked in botany and plant science. This area covers areas like hydroponics, vertical farming and automation in the cannabis industry. 

Investing in growers was popular in 2017 and 2018 for a good reason. Investors believed that the companies with the largest supply would be the winners. But as the industry failed to launch as expected, many of these companies became oversupplied. However, if and when the cannabis industry begins to fire on all cylinders, this supply-demand dynamic should change, and these stocks will be the first to move higher. 

Retailers

Retailers are the customer-facing side of the marijuana business. In many cases, a staff has to be familiar with the effects of different marijuana strains and the effect of varying consumption methods. In the case of medical marijuana, staff members may even have pharmacy training.

At this time, many of these businesses are not publicly traded. However, this is an area to watch, as consolidation will likely occur as many growers try to control the entire purchase cycle.  

Manufacturers

Manufacturers include companies in a field known as cannatech. These are tech companies that are bringing their expertise to the cannabis industry. Currently, they help producers with a digital presence by supplying innovative services and solutions that improve the product and customer experience while at the same time complying with federal and state regulations. 

This area also includes companies that help provide the infrastructure for cannabis companies, such as greenhouses. Investing in this sector may include investing in real estate investment trusts (REITs) that own cannabis-related properties.  

Drugmakers

The first thing many investors may consider in this section is CBD oil, one of the first genuinely mainstream products. More effort will go into discovering ways to make cannabis more accessible for medicinal purposes.

"How to invest in CBD oil stocks?" is a different question. Many of these companies are private companies and are likely to stay that way as long as cannabis continues to be a banned substance at the federal level.  

8 Steps for Investing in Cannabis

So, how to invest in marijuana? First, let's consider the opportunity. According to Grand View Market Research, the value of the worldwide legal cannabis market may reach $91.5 billion by 2028. That would mean a compound annual growth rate (CAGR) of 26.3%. 

But like investing in any segment, investing in cannabis requires due diligence. Here are some steps to follow to ensure you understand the opportunities in cannabis investment. 

Step 1: Know what you’re investing in. 

The medical marijuana market is further ahead of the recreational market in terms of being legal in all 50 states. Still, as the chart shows, all states have different regulations.  

Step 2: Decide on what type of cannabis company you want to invest in.

As we listed earlier, there are opportunities to invest in various stages of the cannabis process. 

Step 3: Perform fundamental analysis.

In addition to universal stock research, like looking at a company's management team, understanding its marketing plan and reviewing financial statements, you'll have to become familiar with some specific metrics for the cannabis industry: 

  • All-in cost of sales per gram: A company's total per-gram cost of producing cannabis.
  • Cash cost per gram: A company's total per-gram cost of producing cannabis, excluding the costs associated with amortization, packaging and inventory adjustments.

Step 4: Choose individual stocks or ETFs.

As you might expect, there are a variety of exchange-traded funds (ETFs) that invest in the cannabis industry. These can allow less risk-tolerant investors to gain exposure to this sector.  

Step 5: Invest your money.

For most investors, it's best to build a position slowly when investing in the cannabis industry, which means picking one or two stocks or a single fund to start. You can use simple dollar-cost averaging to increase your position over time.

Step 6: Continually monitor industry events.

Like any other company you invest in, you have to set aside time to keep track of the stocks you own. MarketBeat makes this easy by sending real-time alerts for stocks in your portfolio or watchlist.  

Step 7: Understand the risks.

The cannabis sector has many risks (see below). Some are unique to this industry and others are similar to what you expect from any penny stock.  

Step 8: Let MarketBeat help.

If you haven't done so already, subscribe to MarketBeat All Access to give you immediate free access to our premium reports, such investing in marijuana stocks for beginners. MarketBeat can also be your go-to research for guidance on how to invest in the tech sector

Risks of Investing in Cannabis

There are several risks for those who are investing in marijuana. First, without full legalization at the federal level, it's difficult, if not impossible, for businesses to operate across state borders. That means cannabis companies have to be licensed in several states (known as multistate operators). These companies are having some success, and they are multiplying. But you'll have to invest in more than one of these companies if you want full coverage of the cannabis market.

The second issue has to do with banking. Because marijuana is not legal in every state, many marijuana-related businesses (MRBs) have difficulty accessing traditional banking products. As of September 30, 2019, the Financial Crimes Enforcement Network (FinCEN) reported that 563 banks and 160 credit unions provided banking services to MRBs. 

This number is growing but still represents only a small fraction of the industry. The report doesn't give insight into what financial products these companies were able to access. 

And even for publicly traded stocks, concerns about supply and demand imbalances will continue to plague the industry. Another risk is that many of these stocks trade as over-the-counter (OTC) stocks, which means they may have different liquidity than other publicly traded stocks. These companies are also subject to different levels of accountability regarding providing shareholders with financial information. 

Finally, as investors saw in 2018, many of these companies still operate without much cash on their balance sheet, which can lead to the companies having to take actions that can dilute shareholder value. 

Future of Investing in Cannabis

The cannabis sector has tremendous potential. But it's also got plenty of risk. If you're considering investing in this space, you have to be comfortable with investing in an opaque industry that will face high regulation in the future. 

Is Investing in Cannabis Stocks Right for You?

The legalization of cannabis at the federal level still feels like a question of "when," not "if." With virtually every state legalizing cannabis for medicinal purposes, at the very least, pressure will likely come to bear on Congress at some point.

Chris Markoch

About Chris Markoch

Contributing Author: Retirement, Individual Investing

Chris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.

Contact Chris Markoch via email at CTMarkoch@msn.com.

My Account -